ATE418338T1 - Camptothecin-analoge und verfahren zu ihrer herstellung - Google Patents
Camptothecin-analoge und verfahren zu ihrer herstellungInfo
- Publication number
- ATE418338T1 ATE418338T1 AT98944535T AT98944535T ATE418338T1 AT E418338 T1 ATE418338 T1 AT E418338T1 AT 98944535 T AT98944535 T AT 98944535T AT 98944535 T AT98944535 T AT 98944535T AT E418338 T1 ATE418338 T1 AT E418338T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- alkyl
- hydrogen
- together form
- alkoxyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical class C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003277 amino group Chemical group 0.000 abstract 2
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 125000006592 (C2-C3) alkenyl group Chemical group 0.000 abstract 1
- 125000006593 (C2-C3) alkynyl group Chemical group 0.000 abstract 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 abstract 1
- 102000003915 DNA Topoisomerases Human genes 0.000 abstract 1
- 108090000323 DNA Topoisomerases Proteins 0.000 abstract 1
- 230000007018 DNA scission Effects 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000278 alkyl amino alkyl group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000004103 aminoalkyl group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 abstract 1
- -1 carbamoyloxy group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
- C07F7/0814—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/0825—Preparations of compounds not comprising Si-Si or Si-cyano linkages
- C07F7/083—Syntheses without formation of a Si-C bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/921,102 US6150343A (en) | 1993-06-30 | 1997-08-29 | Camptothecin analogs and methods of preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE418338T1 true ATE418338T1 (de) | 2009-01-15 |
Family
ID=25444921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98944535T ATE418338T1 (de) | 1997-08-29 | 1998-08-26 | Camptothecin-analoge und verfahren zu ihrer herstellung |
Country Status (9)
| Country | Link |
|---|---|
| US (6) | US6150343A (enExample) |
| EP (1) | EP1017399B1 (enExample) |
| JP (1) | JP4903936B2 (enExample) |
| AT (1) | ATE418338T1 (enExample) |
| AU (1) | AU760543B2 (enExample) |
| CA (1) | CA2302226C (enExample) |
| DE (1) | DE69840388D1 (enExample) |
| ES (1) | ES2320183T3 (enExample) |
| WO (1) | WO1999009996A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6150343A (en) * | 1993-06-30 | 2000-11-21 | University Of Pittsburgh | Camptothecin analogs and methods of preparation thereof |
| US6743917B2 (en) | 1993-06-30 | 2004-06-01 | University Of Pittsburgh | Camptothecin analogs and methods of preparation thereof |
| US6136978A (en) * | 1993-06-30 | 2000-10-24 | University Of Pittsburgh | Camptothecin analogs and methods of preparation thereof |
| FR2754179B1 (fr) | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
| US6207832B1 (en) * | 1999-04-09 | 2001-03-27 | University Of Pittsburgh | Camptothecin analogs and methods of preparation thereof |
| WO2002062340A1 (en) * | 2001-02-07 | 2002-08-15 | University Of Kentucky Research Foundation | Highly lipophilic camptothecin prodrugs, methods of preparation, and formulations thereof |
| US6372906B1 (en) | 2001-04-12 | 2002-04-16 | University Of Pittsburgh | Synthesis of silyl camptothecins and silyl homocamptothecins |
| US6723853B2 (en) | 2001-08-27 | 2004-04-20 | University Of Pittsburgh | Intermediates and methods of preparation of intermediates in the enantiomeric synthesis of (20R)homocamptothecins and the enantiomeric synthesis of (20R)homocamptothecins |
| AU2003239538A1 (en) * | 2002-05-22 | 2003-12-12 | University Of Pittsburgh | Synthesis of polycyclic quinolines |
| CA2548543C (en) | 2003-12-17 | 2012-01-03 | Bionumerik Pharmaceuticals, Inc. | Process for making camptothecin derivatives |
| US7346153B2 (en) * | 2004-11-12 | 2008-03-18 | International Business Machines Corporation | Dynamically alerting callers of changes to menu structures in a telephone prompting system |
| PE20080145A1 (es) | 2006-03-21 | 2008-02-11 | Janssen Pharmaceutica Nv | Tetrahidro-pirimidoazepinas como moduladores de trpv1 |
| AU2007232206B2 (en) | 2006-03-30 | 2013-04-04 | Drais Pharmaceuticals, Inc. | Camptothecin-cell penetrating peptide conjugates and pharmaceutical compositions containing the same |
| JP5467046B2 (ja) * | 2007-10-16 | 2014-04-09 | バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド | Ｃ７−置換カンプトテシン類似体 |
| HUE031374T2 (en) * | 2007-10-16 | 2017-07-28 | Bionumerik Pharmaceuticals Inc | C10-substituted camptothecin analogs |
| WO2009078999A1 (en) | 2007-12-17 | 2009-06-25 | Janssen Pharmaceutica N.V. | Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1 |
| EP3209666B1 (en) * | 2014-10-22 | 2019-08-21 | Vivacitas Oncology Inc. | Methods and systems for camptothecin analog synthesis |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5405963A (en) * | 1993-06-10 | 1995-04-11 | Smithkline Beecham Corporation | Process for asymmetric total synthesis of camptothecin analogues |
| US6150343A (en) * | 1993-06-30 | 2000-11-21 | University Of Pittsburgh | Camptothecin analogs and methods of preparation thereof |
| US6743917B2 (en) * | 1993-06-30 | 2004-06-01 | University Of Pittsburgh | Camptothecin analogs and methods of preparation thereof |
| US6211371B1 (en) | 1993-06-30 | 2001-04-03 | University Of Pittsburgh | Intermediates in the synthesis of camptothecin and related compounds and synthesis thereof |
| US6252079B1 (en) * | 1993-06-30 | 2001-06-26 | University Of Pittsburgh | Intermediates in the synthesis of camptothecin and related compounds and synthesis thereof |
| US5744605A (en) | 1993-06-30 | 1998-04-28 | University Of Pittsburgh | Intermediates in the synthesis of (+) camptothecin and related compounds and synthesis thereof |
| US6136978A (en) * | 1993-06-30 | 2000-10-24 | University Of Pittsburgh | Camptothecin analogs and methods of preparation thereof |
| DE69728152T2 (de) * | 1996-08-19 | 2004-08-05 | Bionumerik Pharmaceuticals, Inc., San Antonio | Hoch-lipophile campothecin-derivate |
| US6169080B1 (en) * | 1997-02-13 | 2001-01-02 | Bionumerik Pharmaceuticals, Inc. | Highly lipophilic camptothecin derivatives |
| DK1017675T3 (da) * | 1997-02-14 | 2006-10-16 | Bionumerik Pharmaceuticals Inc | Stærkt lipofile camptothecinderivater |
| US6948279B1 (en) | 1997-04-22 | 2005-09-27 | Caldwell Manufacturing Company | Support system for laterally removable sash |
| US6057303A (en) * | 1998-10-20 | 2000-05-02 | Bionumerik Pharmaceuticals, Inc. | Highly lipophilic Camptothecin derivatives |
| US6403604B1 (en) * | 2001-03-01 | 2002-06-11 | California Pacific Medical Center | Nitrogen-based camptothecin derivatives |
| US7687497B2 (en) * | 2007-10-16 | 2010-03-30 | Bionumerik Pharmaceuticals, Inc. | C10-substituted camptothecin analogs |
-
1997
- 1997-08-29 US US08/921,102 patent/US6150343A/en not_active Expired - Lifetime
-
1998
- 1998-08-26 AT AT98944535T patent/ATE418338T1/de active
- 1998-08-26 AU AU92056/98A patent/AU760543B2/en not_active Ceased
- 1998-08-26 JP JP2000507386A patent/JP4903936B2/ja not_active Expired - Fee Related
- 1998-08-26 EP EP98944535A patent/EP1017399B1/en not_active Expired - Lifetime
- 1998-08-26 DE DE69840388T patent/DE69840388D1/de not_active Expired - Lifetime
- 1998-08-26 ES ES98944535T patent/ES2320183T3/es not_active Expired - Lifetime
- 1998-08-26 WO PCT/US1998/017683 patent/WO1999009996A1/en not_active Ceased
- 1998-08-26 CA CA2302226A patent/CA2302226C/en not_active Expired - Fee Related
-
2000
- 2000-08-07 US US09/633,561 patent/US6455699B1/en not_active Expired - Lifetime
-
2002
- 2002-09-20 US US10/251,153 patent/US20030105324A1/en not_active Abandoned
-
2003
- 2003-07-29 US US10/629,432 patent/US7271159B2/en not_active Expired - Fee Related
-
2007
- 2007-07-09 US US11/825,729 patent/US7514418B2/en not_active Expired - Fee Related
- 2007-10-31 US US11/981,059 patent/US7655640B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US6150343A (en) | 2000-11-21 |
| AU760543B2 (en) | 2003-05-15 |
| WO1999009996A1 (en) | 1999-03-04 |
| US7271159B2 (en) | 2007-09-18 |
| US20030105324A1 (en) | 2003-06-05 |
| AU9205698A (en) | 1999-03-16 |
| US6455699B1 (en) | 2002-09-24 |
| CA2302226A1 (en) | 1999-03-04 |
| US7655640B2 (en) | 2010-02-02 |
| ES2320183T3 (es) | 2009-05-19 |
| CA2302226C (en) | 2010-08-24 |
| DE69840388D1 (de) | 2009-02-05 |
| JP4903936B2 (ja) | 2012-03-28 |
| US7514418B2 (en) | 2009-04-07 |
| US20070259905A1 (en) | 2007-11-08 |
| EP1017399A1 (en) | 2000-07-12 |
| JP2001513567A (ja) | 2001-09-04 |
| EP1017399A4 (en) | 2002-11-13 |
| EP1017399B1 (en) | 2008-12-24 |
| US20040029835A1 (en) | 2004-02-12 |
| US20080269169A1 (en) | 2008-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE418338T1 (de) | Camptothecin-analoge und verfahren zu ihrer herstellung | |
| ATE128975T1 (de) | Harnstoffderivate, verfahren zu ihrer herstellung und diese enthaltende medikamente. | |
| HU912143D0 (en) | Plant protecting preparations containing o-benzyl-oxymeters and process for the production of the active agents | |
| DE68906552D1 (de) | Camptothecin-derivate und verfahren zu ihrer herstellung. | |
| ATE127801T1 (de) | Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung. | |
| DE19575012I2 (de) | Carboxyalkyl-Dipeptide Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| ATE172731T1 (de) | Pyrazolopyridinverbindung und verfahren zu ihrer herstellung | |
| ES8404990A1 (es) | Un procedimiento para la preparacion de derivados de prolina. | |
| FI961914A0 (fi) | Lyhytvaikutteiset dihydropyridiinit | |
| DE58904143D1 (de) | Arylalkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel. | |
| GB8426200D0 (en) | Chemical compounds | |
| FR2679555B1 (fr) | Nouveaux derives de l'uree, leur preparation et leur application en therapeutique. | |
| ATA49688A (de) | Neue pyridazinonderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
| BG105855A (en) | 2-aminopyridines containing fused ring substituents | |
| EP0335979A4 (en) | Thienopyrimidine derivatives | |
| DK0819108T3 (da) | Fremgangsmåde til fremstilling af galanthaminderivater ved asymmetrisk reduktion | |
| DE69806189D1 (de) | Acronycinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
| EP0315434A3 (en) | Pyridoxal hydrazone derivatives their production and use and pharmaceutical compositions containing the same | |
| ES8603417A1 (es) | Un procedimiento para preparar derivados de dihidropiridina | |
| WO1998003540A3 (en) | 1,2-substituted cycloalkane derivatives as thrombine inhibitors, a process for the preparation thereof and the use thereof in pharmaceutical formulations | |
| ATE58135T1 (de) | 1,3-oxathianderivate. | |
| IE901104L (en) | New bronchospasmolytic compounds and process for their¹preparation | |
| DE68907857D1 (de) | Beta-d-phenylthioxyloside, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| WO2003074524A3 (en) | Mappicine analogs, intermediates in the synthesis of mappicine analogs and methods of synthesis of mappicine analogs | |
| OA09486A (fr) | "Nouveaux dérivés de la 4H-Pyrrolo (1,2-a) thiéno (3,2-f) (1,4) -diazépine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent". |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1017399 Country of ref document: EP |